130209-82-4,
CHEMBL364375,
trans Latanoprost,
C26H40O5,
913258-34-1,
Latanoprost [USAN:INN:BAN],
Isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate,
XA 41,
latanoprost (isopropyl ester),
latanaprost,
trans-Latanoprost,
5-trans-Latanoprost,
PhXA34,
AC1NQZZ7,
Xalatan Fixed Flow Device,
LATANOPROST (PHXA41),
SCHEMBL1286379,
SCHEMBL1649402,
CHEBI:94503,
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-, 1-methylethyl ester, (1R-(1-alpha(Z),2-beta(R*),3-alpha,5-alpha))-,
ZINC4097345,
2077AH,
BDBM50150899,
PDSP2_001702,
AKOS016002154,
API0003129,
AJ-47997,
BC208340,
LS-74633,
TC-147663,
Z-3157,
J-502634,
13,14-dihydro-15(R)-17-phenyl-18,19,20-trinor-prostaglandin-2-alpha-isopropyl ester,
(E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-((R)-3-hydroxy-5-phenyl-pentyl)-cyclopentyl]-hept-5-enoic acid isopropyl ester,
(Z)-isopropyl 7-((1R,2R)-3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate,
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-,1-methylethyl ester, (1R-(1-alpha(Z),2-beta(R*),3-alpha,5-alpha))-,
isopropyl (E)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate,
propan-2-yl (E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate,
latanoprost,
Xalatan,
5,6-trans-Latanoprost,
PhXA 41,
PhXA41,
UNII-6Z5B6HVF6O,
Latanoprost Related Compound A,
Latanoprost [USAN:BAN:INN],
C26-H40-O5,
CID5282380,
CS-O-20032,
Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate,